Melissa Arulappan, Head, Corporate Communications, IQVIA India elaborates on the learnings for journalists from the pandemic to sustain productive discussions around clinical trials and ensure greater awareness and acceptance amongst the general public
My article based on views I presented from a media/communications perspective at a recent clinical research conference where I was a panelist with regulators, investigators, industry speaking on drug development in a pandemic